Skip to content
DataLookout
Menu

Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. clinical trial pipeline

Get alerts when Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors Enrollment increased: 30 → 66 participants Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.Phase 1 NCT07923214
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-06 NCT07923214 A Phase I Dose Escalation Study of CG-7321 Monotherapy or Combination Therapy in Advanced… Phase 1 Recruiting

Active trials by phase

Phase 1
1

Disease areas by active trials

Get alerts when Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free